The global artificial intelligence in magnetic resonance imaging (MRI) market size accounted for USD 6.48 billion in 2024, grew to USD 7.12 billion in 2025 and is predicted to surpass around USD 16.65 billion by 2034, representing a healthy CAGR of 9.89% between 2024 and 2034. The North America artificial intelligence in magnetic resonance imaging (MRI) market size is calculated at USD 2.66 billion in 2024 and is expected to grow at a fastest CAGR of 10.01% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Intelligence in MRI Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Intelligence in MRI Market, by Clinical Applications, 2024-2034
8.1.1. Musculoskeletal
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Colon
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Prostate
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Liver
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Cardiovascular
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Neurology
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Lung
8.1.7.1. Market Revenue and Forecast (2021-2034)
8.1.8. Breast
8.1.8.1. Market Revenue and Forecast (2021-2034)
8.1.9. Others
8.1.9.1. Market Revenue and Forecast (2021-2034)
9.1. Artificial Intelligence in MRI Market, by Offering Type, 2024-2034
9.1.1. Hardware
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Software
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Services
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Artificial Intelligence in MRI Market, by Technology, 2024-2034
10.1.1. Deep learning
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Machine learning
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Computer vision
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. NLP (Natural Language Processing)
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Speech recognition
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.5. Querying method
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.5. Other
10.1.5.1. Market Revenue and Forecast (2021-2034)
11.1. Artificial Intelligence in MRI Market, by Deployment Type, 2024-2034
11.1.1. On-premise
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Cloud
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. Artificial Intelligence in MRI Market, by End-User, 2024-2034
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Clinics
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Research and laboratories
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.1.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.1.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.1.5. Market Revenue and Forecast, by End-User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.1.6.5. Market Revenue and Forecast, by End-User (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.1.7.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.1.7.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.7.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.1.7.5. Market Revenue and Forecast, by End-User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.2.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.2.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.2.5. Market Revenue and Forecast, by End-User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.7. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.2.8. Market Revenue and Forecast, by End-User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.10. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.2.11. Market Revenue and Forecast, by End-User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.2.13. Market Revenue and Forecast, by End-User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.2.15. Market Revenue and Forecast, by End-User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.3.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.3.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.3.5. Market Revenue and Forecast, by End-User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.3.7. Market Revenue and Forecast, by End-User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.3.9. Market Revenue and Forecast, by End-User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End-User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.4.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.4.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.4.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.4.7. Market Revenue and Forecast, by End-User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.4.9. Market Revenue and Forecast, by End-User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End-User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.5.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.5.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.5.5. Market Revenue and Forecast, by End-User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.5.7. Market Revenue and Forecast, by End-User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Clinical Applications (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Offering Type (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Deployment Type (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End-User (2021-2034)
14.1. IBM Corporation
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Bay Labs Inc
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Resonance Health Ltd
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Zebra Medical Vision Inc
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Samsung Electronics Co.Ltd
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Arterys Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Koninklijke Philips N.V.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Nuance Communications Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Siemens Healthneer AG
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. OrCam
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample